Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine)
Treatment for Visceral leishmaniasis
Effectiveness
98%
Safety Score
55%
Clinical Trials
25
Participants
2.5K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
55
DangerousModerateSafe
Treatment Details
0
Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine) Outcomes
for Visceral leishmaniasis
Efficacy Outcomes
Overall Effectiveness
+98%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov